Concepedia

Hui Xu

HX

88

Publications

5K

Citations

36

H-Index

1997

Active since

Affiliations

National Institutes of Health(Current)

National Cancer Institute

Harbin Medical University

Third Affiliated Hospital of Harbin Medical University

Stanford University

Hui Xu is an author at National Institutes of Health specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

1997–2024

88

Publications

88

Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment

Anne Marie Lewis, Sheelu Varghese, Hui Xu et al. · Journal of Translational Medicine · 2006 · 452 citations · Full text

The 37/67-Kilodalton Laminin Receptor Is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9

Bassel Akache, Dirk Grimm, Kusum Pandey et al. · Journal of Virology · 2006 · 416 citations · Full text

, , +14

Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor

James N. Kochenderfer, Steven A. Feldman, Yangbing Zhao et al. · Journal of Immunotherapy · 2009 · 404 citations · Full text

Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions

Paul F. Robbins, Yong F. Li, Mona El‐Gamil et al. · The Journal of Immunology · 2008 · 374 citations · Full text

Cadmium-Induced Apoptosis in Primary Rat Cerebral Cortical Neurons Culture Is Mediated by a Calcium Signaling Pathway

Yan Yuan, Chenyang Jiang, Hui Xu et al. · PLoS ONE · 2013 · 167 citations · Full text

Rows per page

1–5 of 88